Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
Follow TEM
Alert me
Tempus AI, Inc. (TEM) P/B ratio
As of 5 November 2026, Tempus AI, Inc. (TEM) trades at a P/B ratio of 25.5×. Over the past ten years it has ranged from 0.0× (June 2024) to 239× (November 2024); the current reading is higher than 38% of that period. That is above the Health Information Services industry median of 1.9× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 20.9× | (70.84%) |
| FY2024 | 71.8× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 29.7× | 26.68% |
| Jun 2026 | 23.4× | 20.59% |
| Mar 2026 | 19.4× | (7.25%) |
| Dec 2025 | 20.9× | (24.67%) |
| 11 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| WAY Waystar Holding Corp. compare | 1.4× |
| PRVA Privia Health Group, Inc. compare | 3.5× |
| HQY HealthEquity, Inc. compare | 4.3× |
| BTSG BrightSpring Health Services, Inc. compare | 6.3× |
| DOCS Doximity, Inc. compare | 6.4× |
| VEEV Veeva Systems Inc. compare | 6.8× |
| HTFL Heartflow, Inc. compare | 16.1× |
| TEM Tempus AI, Inc. | 25.5× |
| HNGE Hinge Health Inc. compare | 26.6× |
| Health Information Services industry median | 1.9× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on TEM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement